YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Nitric Oxide Levels in Response To the Patients With Different Stage of Diabetes

dc.authorid Ozcelik, Oguz/0000-0002-2391-9883
dc.authorscopusid 55886751100
dc.authorscopusid 56318101800
dc.authorwosid Ozcelik, Oguz/Adw-0044-2022
dc.contributor.author Ozcelik, O.
dc.contributor.author Algul, S.
dc.date.accessioned 2025-05-10T17:28:51Z
dc.date.available 2025-05-10T17:28:51Z
dc.date.issued 2017
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Ozcelik, O.] Firat Univ, Fac Med, Dept Physiol, Elazig, Turkey; [Algul, S.] Yuzuncu Yil Univ, Fac Med, Dept Physiol, Van, Turkey en_US
dc.description Ozcelik, Oguz/0000-0002-2391-9883 en_US
dc.description.abstract The association between hyperglycaemia and serum nitric oxide (NO) levels has not yet been fully clarified. Thus, it was aimed to evaluate the concentration of NO metabolites (nitrate, nitrite) in diabetic patients and to find the relationship between hyperglycaemia and serum NO levels in diabetic and prediabetic patients, and control groups. In this study, 100 subjects were divided into 3 groups: healthy control (n=20), prediabetic (n=40) and diabetic (n=40). Glycemic control was assessed using glycated hemoglobin (HbA1c). Nitrate and nitrite levels were measured using the Griess reagent. NO was obtained from the sum of nitrates and nitrites. The serum NO level was higher in diabetic (53.4 +/- 2.0 mu M) and prediabetic patients (51.6 +/- 1.6 mu M) as compared to that in the control (45.6 +/- 1.2 mu M), (p< 0.05). The NO level was not significantly different in diabetic and prediabetic patients. Higher levels of serum glucose, insulin and HOMA-IR may be responsible for the activation of endothelial cells to increase NO levels. This study supports the role of insulin resistance in increased NO levels in both diabetic and prediabetic patients. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.14715/cmb/2017.63.1.10
dc.identifier.endpage 52 en_US
dc.identifier.issn 0145-5680
dc.identifier.issn 1165-158X
dc.identifier.issue 1 en_US
dc.identifier.pmid 28234625
dc.identifier.scopus 2-s2.0-85015348417
dc.identifier.scopusquality Q4
dc.identifier.startpage 49 en_US
dc.identifier.uri https://doi.org/10.14715/cmb/2017.63.1.10
dc.identifier.uri https://hdl.handle.net/20.500.14720/12166
dc.identifier.volume 63 en_US
dc.identifier.wos WOS:000397291600010
dc.identifier.wosquality Q4
dc.language.iso en en_US
dc.publisher C M B Assoc en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Nitric Oxide en_US
dc.subject Diabetes en_US
dc.subject Prediabetes en_US
dc.subject Hyperglycaemia en_US
dc.subject Endothelial Dysfunction en_US
dc.title Nitric Oxide Levels in Response To the Patients With Different Stage of Diabetes en_US
dc.type Article en_US

Files